
Nautilus Biotechnology rose 10.5% from $1.90 to $2.10, behind the S&P 500's +11.2%. Its worst day was Jul 28 (−27.7%), and its low came Aug 18 at $0.85.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Nautilus Biotechnology shares rose 22.8%, while the S&P 500 rose 0.2%.
+22.8% · S&P 500 +0.2%
EPS of $-0.11 beat the $-0.14 estimate on $0.00 revenue.
−16.3% · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
Nautilus Biotechnology closed at its highest level of the year, 107.9% above where the year started.
+9.1% · S&P 500 −0.3%
EPS of $-0.12 beat the $-0.14 estimate on $0.00 revenue.
+0.8% · S&P 500 −0.5%
EPS of $-0.11 beat the $-0.14 estimate on $190,000.00 revenue.
−27.7%, the year's worst day · S&P 500 +0.2%
Nautilus Biotechnology closed at its lowest level of the year, 55.2% below where the year started.
−3.3% · S&P 500 −0.7%
Nautilus Biotechnology shares rose 20.7%, while the S&P 500 fell 0.5%.
+20.7% · S&P 500 −0.5%
Nautilus Biotechnology shares rose 24.8%, while the S&P 500 rose 0.7%.
+24.8% · S&P 500 +0.7%
Nautilus Biotechnology shares rose 27.7%, while the S&P 500 rose 0.4%.
+27.7%, the year's best day · S&P 500 +0.4%
EPS of $-0.12 beat the $-0.14 estimate on $200,000.00 revenue (est. $205,000.00).
+18.4% · S&P 500 +0.6%
Where it ended: a close of $2.10 on Nov 16, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $-0.14, revenue est. $270,000.00).
Nothing in the past 12 months.
All NAUT dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NAUT and SPY from Benzinga historical bars. Not investment advice.